AstraZeneca PLC is 13.6x more valuable than Roivant Sciences Ltd. by market capitalization ($286.27 B vs $21.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ROIV | AZN |
|---|---|---|
| Market cap | $21.12 B | $286.27 B |
| US-listed rank | #603 | #45 |
| Revenue (latest FY) | $8.26M | - |
| Net income (latest FY) | -$299.77M | - |
| Net margin | -3629.2% | - |
| SEC filings | 868 | 1,004 |
AstraZeneca PLC is 13.6x more valuable than Roivant Sciences Ltd. by market capitalization ($286.27 B vs $21.12 B).
Full pages: Roivant Sciences Ltd. and AstraZeneca PLC, or browse the full rankings.